Dr. Fang Fan earned her medical degree from Shanghai Medical School at Fudan University in China. She then began her two decades-long association with the University of Kansas Medical Center in Kansas City, Kansas, earning a Ph.D., completing her pathology residency and cytopathology fellowship, staying as a faculty, and ultimately rising to Director of Cytopathology and Barbara F. Atkinson Endowed Professor at the Pathology department. Dr. Fan joined City of Hope pathology department in 2021 and she is currently Clinical Professor and Director of Cytopathology at City of Hope Medical Center in Duarte, California.

Dr. Fan has more than 100 scholarly articles and many national presentations in the fields of cytopathology and breast pathology. She has given Cytopathology lectures/Microscopic sessions in the Oakstone Lecture Series, Osler Cytopathology Board Review courses, CAP annual meetings, ASC annual meetings, and USCAP annual meetings. She is the chief editor of a Cytopathology Review book which is currently in its third edition. Dr. Fan has served on the Cytopathology Committee of the College of American Pathologists (CAP), and Membership Committee, International Liaison Committee, and Scientific Program Committee of the American Society of Cytopathology (ASC).

Dr. Cai earned his medical degree from Wenzhou Medical Univeristy in China. He completed his residency in Anatomic and Clinical Pathology at New York University Medical Center, where he also completed a fellowship in cytopathology. He is a board-certified pathologist and cytopathologist. He is currently Professor of Pathology and Associate Director of Cytopathology in the Department of Pathology, Yale University School of Medicine.

Dr. Cai's research interest includes molecular and biomarker testing in lung, pancreas, and thyroid cancers. He is a member of the Cancer Signaling Networks Program at Yale Cancer Center. He has published over 120 peer-reviewed articles. He is an editor for the book entitled “Rapid On-site Evaluation: A Parctical Guide”, and is a contributor for the WHO Reporting System for Pancreaticobiliary Cytopathology. He currently serves on the Progressive Evaluation Committee of American Society of Cytopathology (ASC) and the Membership Committee of International Association for the Study of Lung Cancer (IASLC).